11-2888464-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000455942.4(SLC22A18AS):n.653C>T variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00002 in 1,551,502 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000455942.4 non_coding_transcript_exon
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC22A18AS | ENST00000455942.4 | n.653C>T | non_coding_transcript_exon_variant | Exon 3 of 3 | 1 | |||||
SLC22A18AS | ENST00000625099.4 | n.810C>T | non_coding_transcript_exon_variant | Exon 4 of 4 | 1 | |||||
SLC22A18AS | ENST00000526203.1 | n.295C>T | non_coding_transcript_exon_variant | Exon 2 of 2 | 3 | |||||
SLC22A18AS | ENST00000702349.1 | n.527C>T | non_coding_transcript_exon_variant | Exon 2 of 2 |
Frequencies
GnomAD3 genomes AF: 0.0000788 AC: 12AN: 152234Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000195 AC: 3AN: 153568Hom.: 0 AF XY: 0.0000123 AC XY: 1AN XY: 81172
GnomAD4 exome AF: 0.0000136 AC: 19AN: 1399268Hom.: 0 Cov.: 33 AF XY: 0.00000725 AC XY: 5AN XY: 690130
GnomAD4 genome AF: 0.0000788 AC: 12AN: 152234Hom.: 0 Cov.: 33 AF XY: 0.000121 AC XY: 9AN XY: 74372
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.478C>T (p.R160C) alteration is located in exon 4 (coding exon 2) of the SLC22A18AS gene. This alteration results from a C to T substitution at nucleotide position 478, causing the arginine (R) at amino acid position 160 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at